LYEL
Lyell Immunopharma, Inc. Common Stock
$26.59
6.50%
+1.65
Notify me if price changes either direction
Buy LYEL stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
539.2M
Enterprise value
263.2M
Trailing PE
-1.1305193145786
Forward PE
-30.214285
PEG Ratio
0.030265871413915
Enterprise to EBITDA
-1.427
Enterprise to revenue
6419.008
Price to book MRQ
1.4878649
Price to sales TTM
13150.524
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
41000
EBITDA
-184380992
Diluted EPS TTM
-23.64
Total Cash (MRQ)
319.6M
Current ratio (MRQ)
10.296
Operating Cash Flow (TTM)
-165015008
LYEL trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
February 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
